Description / Scope of the Technical Need.
We are seeking innovation opportunities to develop dietary supplements or medical devices with dual action to extend our constipation product range. Specifically, we are looking for innovative solutions that can relieve constipation while also addressing associated symptoms such as gas and bloating. Strong scientific or clinical data demonstrating efficacy is essential, along with regulatory compliance in the U.S.
Background.
We offer a range of products for effective treatment of constipation. Example products include:
- Tablets, chews, liquid gels, suppositories, and liquids for effective short- term treatment of occasional constipation
- Capsules for prevention and gentle treatment of chronic constipation.
We are interested in extending our product offering by utilizing substantiated functional ingredient(s) to achieve the symptomatic relief from constipation and gas/bloating in the same timeframe for the onset of action/expected relief.
Key Success Criteria.
Must-have Requirements.
- Strong scientific / clinical data showing efficacy.
- Ideally, the same functional ingredient should provide both constipation relief and gas/ bloating relief (single ingredient with dual benefits vs need for multi-ingredient formulation).
- Functional ingredient(s) should also have similar technical formulation requirements (e.g., be heat resistant, not require gastro-resistant coating).
- Need for regulatory compliance in the US
Preferred Requirements.
- In line with Opella's sustainability initiatives for any tangible solutions
- Costs in-line with current brand offerings
Approaches not of interest.
- Ingredients with a large difference in the onset of action between constipation and gas relief
- Known ingredients on the market e.g. Peppermint Oil, Activated Charcoal, Simethicone, Ginger, Magnesium, etc.
- Ingredients that would require an NDA (New Drug Application)
Target Group.
Adults and children, no specific health conditions
Geographies.
Global
Have a question or simply want to know more?
Any question or adverse reaction related to our products must be addressed via www.sanofi.com.